The first episode in our special three part mini-series.
06.04.2021
Q&A with Dr Mark Kotter: Transforming drug discovery & medical research
IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.
Former CEO Mark Kotter speaks at TEDxCambridgeUniversity
bit.bio CEO spoke about reprogramming human cells at the TEDxCambridgeUniversity ‘Untangling networks’ event.
Cultivated meat and cell therapies opti-ox™ technology underpins both
Today Meatable announced their Series A fundraise of $47 million. Read about the connection to bit.bio.
Leading clinical immunotherapies developer Ramy Ibrahim joins bit.bio as Chief Medical Officer
Press release announcing appointment of Dr Ramy Ibrahim, MD, as Chief Medical Officer.
Bit Bio secures $41.5 M of funding from top life sciences investors
bit.bio closes series A $41.5 million funding.